Diana N. Vikulova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diana N. Vikulova has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Liam R. Brunham
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
5 shared publications - Emilie T. Théberge
Department of Medical Genetics University of British Columbia Vancouver British Columbia Canada
2 shared publications Karin H. Humphries
Centre for Health Evaluation and Outcomes Science, University of British Columbia, Vancouver, Canada
2 shared publicationsSimon N. Pimstone
University of British Columbia
2 shared publicationsA A Belkin
1 shared publicationAlejandro Fuerte-Hortigon
Vancouver Stroke Program, Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
1 shared publication
Latest Publications
- 19 July 2026
- Published by SAGE Publications in International Journal of Stroke
Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials
Background: Venous thrombosis and venous thromboembolism (VTE) are important causes and complications of stroke. They may complicate acute stroke as deep venous thrombosis or pulmonary embolism (DVT/PE), contribute causally to ischemic stroke through paradoxical embolism from a patent foramen ovale (PFO), or present directly as cerebral venous thrombosis (CVT). Despite shared pathophysiological features and overlapping antithrombotic strategies, these conditions are typically considered separately, fragmenting evidence and limiting the exchange of concepts. Purpose: We therefore convened experts across both stroke neurology and thrombosis medicine fields to examine these conditions under a unifying venous theme and define priorities for future clinical trials. Methods: Thirty-two stroke and thrombosis clinicians and researchers identified research priorities across three domains: prevention of VTE after stroke, secondary prevention after PFO-related stroke, and acute and long-term management of CVT. Structured discussions were guided by the PICO (Population, Intervention, Comparison, Outcome) framework, followed by a Delphi survey to establish consensus. Priority questions centered on the balance between thrombosis prevention and bleeding risk and the optimal timing, duration, and choice of DVT/PE prophylaxis after stroke; the optimal antithrombotic strategy for patients awaiting or forgoing PFO closure; and, for CVT, the role of endovascular therapy in severe disease and the optimal duration of secondary prevention (Graphical Abstract). Across domains, the group prioritized pragmatic and platform trial designs, integration with international registries to address the rarity of CVT, and patient-oriented outcomes that extend beyond functional recovery. Conclusions: By considering these venous conditions together and bridging stroke and thrombosis disciplines, this work defines priority questions to address persistent evidence gaps, harmonize practice, and improve patient-centered outcomes.
- 19 July 2026
- Published by SAGE Publications in International Journal of Stroke
Venous Thrombotic and Thromboembolic Considerations in Stroke: An Expert Meeting Report on Future Directions for Clinical Trials
Background: Venous thrombosis and venous thromboembolism (VTE) are important causes and complications of stroke. They may complicate acute stroke as deep venous thrombosis or pulmonary embolism (DVT/PE), contribute causally to ischemic stroke through paradoxical embolism from a patent foramen ovale (PFO), or present directly as cerebral venous thrombosis (CVT). Despite shared pathophysiological features and overlapping antithrombotic strategies, these conditions are typically considered separately, fragmenting evidence and limiting the exchange of concepts. Purpose: We therefore convened experts across both stroke neurology and thrombosis medicine fields to examine these conditions under a unifying venous theme and define priorities for future clinical trials. Methods: Thirty-two stroke and thrombosis clinicians and researchers identified research priorities across three domains: prevention of VTE after stroke, secondary prevention after PFO-related stroke, and acute and long-term management of CVT. Structured discussions were guided by the PICO (Population, Intervention, Comparison, Outcome) framework, followed by a Delphi survey to establish consensus. Priority questions centered on the balance between thrombosis prevention and bleeding risk and the optimal timing, duration, and choice of DVT/PE prophylaxis after stroke; the optimal antithrombotic strategy for patients awaiting or forgoing PFO closure; and, for CVT, the role of endovascular therapy in severe disease and the optimal duration of secondary prevention (Graphical Abstract). Across domains, the group prioritized pragmatic and platform trial designs, integration with international registries to address the rarity of CVT, and patient-oriented outcomes that extend beyond functional recovery. Conclusions: By considering these venous conditions together and bridging stroke and thrombosis disciplines, this work defines priority questions to address persistent evidence gaps, harmonize practice, and improve patient-centered outcomes.
- Open Access
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e046415
Temporal Trends in Lipid‐Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery Disease
Background: Patients with premature coronary artery disease (CAD) have high rates of recurrent events and death. Information on long‐term adherence to lipid‐lowering therapy (LLT) and trends in medication‐taking behavior in premature CAD is limited. We assessed temporal trends in LLT, factors associated with adherence to LLT, and the consequences of low adherence in a longitudinal cohort of patients with premature CAD. Methods: Using a cardiovascular registry and administrative databases, we analyzed temporal changes in rates and predictors of adherence to LLT as well as the association between adherence and cardiovascular outcomes in patients with premature obstructive CAD from 2000 to 2017. Results: Among 11 411 patients with premature CAD, 27.6% were women and the mean±SD age was 46.1±5.05 years. The proportion with good first‐year adherence to LLT increased from 54.9% to 71.4% ( P P P <0.001). More severe presentation, revascularization at presentation, absence of chronic kidney disease, and nonsmoking were consistently associated with better adherence across the study time frame. Rural residence, female sex, and substance use disorder were associated with poor adherence only in later years. Good adherence was associated with a lower risk of cardiovascular outcomes, including death (hazard ratio [HR], 0.45 [95% CI, 0.39–0.55]) and myocardial infarction (HR, 0.53 [95% CI, 0.45–0.63]). Conclusions: Use of high‐intensity LLT and short‐term adherence are improving in patients with premature CAD, but different strategies are needed to increase long‐term adherence to prevent recurrent cardiovascular events.
- 19 May 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (10) , e046415
Open AccessTemporal Trends in Lipid‐Lowering Therapy Use and Adherence in Patients With Premature Coronary Artery Disease
Background: Patients with premature coronary artery disease (CAD) have high rates of recurrent events and death. Information on long‐term adherence to lipid‐lowering therapy (LLT) and trends in medication‐taking behavior in premature CAD is limited. We assessed temporal trends in LLT, factors associated with adherence to LLT, and the consequences of low adherence in a longitudinal cohort of patients with premature CAD. Methods: Using a cardiovascular registry and administrative databases, we analyzed temporal changes in rates and predictors of adherence to LLT as well as the association between adherence and cardiovascular outcomes in patients with premature obstructive CAD from 2000 to 2017. Results: Among 11 411 patients with premature CAD, 27.6% were women and the mean±SD age was 46.1±5.05 years. The proportion with good first‐year adherence to LLT increased from 54.9% to 71.4% ( P P P <0.001). More severe presentation, revascularization at presentation, absence of chronic kidney disease, and nonsmoking were consistently associated with better adherence across the study time frame. Rural residence, female sex, and substance use disorder were associated with poor adherence only in later years. Good adherence was associated with a lower risk of cardiovascular outcomes, including death (hazard ratio [HR], 0.45 [95% CI, 0.39–0.55]) and myocardial infarction (HR, 0.53 [95% CI, 0.45–0.63]). Conclusions: Use of high‐intensity LLT and short‐term adherence are improving in patients with premature CAD, but different strategies are needed to increase long‐term adherence to prevent recurrent cardiovascular events.
- 3 October 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (10) , S208-S209
INCIDENCE, RECURRENCE, AND ETHNICITY SPECIFIC RISK FACTORS FOR PREMATURE CORONARY ARTERY DISEASE IN SOUTH ASIANS AND CAUCASIANS
- 3 October 2023
- Published by Elsevier in Canadian Journal of Cardiology
- Vol. 39 (10) , S208-S209
INCIDENCE, RECURRENCE, AND ETHNICITY SPECIFIC RISK FACTORS FOR PREMATURE CORONARY ARTERY DISEASE IN SOUTH ASIANS AND CAUCASIANS
- Open Access
Risk factor profiles of young women with vasomotor non-obstructive versus obstructive coronary syndromes: Importance of non-traditional and sex-specific risk factors
Background Heart disease is the leading cause of premature death for women in Canada. Ischemic heart disease (IHD) is categorized as myocardial infarction (MI) with no obstructive coronary artery disease (MINOCA), ischemia with no obstructive coronary arteries (INOCA), and atherosclerotic obstructive coronary artery disease (CAD) with MI (MI-CAD) or without MI (non-MI CAD). This study aims to study the prevalence of traditional and non-traditional IHD risk factors and their relationships with (M)INOCA compared to MI-CAD and non-MI CAD in young women. Methods This study investigated women who presented with premature (≤55 years old) vasomotor entities of (M)INOCA or obstructive CAD confirmed by coronary angiography, who are currently enrolled in either the Leslie Diamond Women’s Heart Health Clinic Registry (WHC) or the Study to Avoid cardioVascular Events in BC (SAVEBC). Univariable and multivariable regression models were applied to investigate associations of risk factors with odds of (M)INOCA, MI-CAD or non-MI CAD. Results A total of 254 women enrolled between 2015-2022 were analyzed: 77 INOCA and 37 MINOCA from the WHC and 66 with non-MI CAD and 74 MI-CAD from SAVEBC. Regression analyses demonstrated that migraines and preeclampsia/gestational hypertension were the most significant risk factors with higher likelihood to associate with premature (M)INOCA relative to obstructive CAD. Conversely, the presence of diabetes and a current or previous smoking history had the highest likelihood to associate with premature CAD. Conclusion There are significant differences in the risk factor profiles of patients with premature (M)INOCA compared to obstructive CAD.
Open AccessRisk factor profiles of young women with vasomotor non-obstructive versus obstructive coronary syndromes: Importance of non-traditional and sex-specific risk factors
Background Heart disease is the leading cause of premature death for women in Canada. Ischemic heart disease (IHD) is categorized as myocardial infarction (MI) with no obstructive coronary artery disease (MINOCA), ischemia with no obstructive coronary arteries (INOCA), and atherosclerotic obstructive coronary artery disease (CAD) with MI (MI-CAD) or without MI (non-MI CAD). This study aims to study the prevalence of traditional and non-traditional IHD risk factors and their relationships with (M)INOCA compared to MI-CAD and non-MI CAD in young women. Methods This study investigated women who presented with premature (≤55 years old) vasomotor entities of (M)INOCA or obstructive CAD confirmed by coronary angiography, who are currently enrolled in either the Leslie Diamond Women’s Heart Health Clinic Registry (WHC) or the Study to Avoid cardioVascular Events in BC (SAVEBC). Univariable and multivariable regression models were applied to investigate associations of risk factors with odds of (M)INOCA, MI-CAD or non-MI CAD. Results A total of 254 women enrolled between 2015-2022 were analyzed: 77 INOCA and 37 MINOCA from the WHC and 66 with non-MI CAD and 74 MI-CAD from SAVEBC. Regression analyses demonstrated that migraines and preeclampsia/gestational hypertension were the most significant risk factors with higher likelihood to associate with premature (M)INOCA relative to obstructive CAD. Conversely, the presence of diabetes and a current or previous smoking history had the highest likelihood to associate with premature CAD. Conclusion There are significant differences in the risk factor profiles of patients with premature (M)INOCA compared to obstructive CAD.
- Open Access
- 1 June 2020
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 2, 100036
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
- 1 June 2020
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 2, 100036
Open AccessLipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
- Open Access
- 16 July 2019
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (14) , e012178
Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex‐Related Differences, 2000 to 2016
Background: The incidence of atherosclerotic cardiovascular disease has declined in the past 2 decades. However, these benefits may not extend to young patients. The objective of this work was to assess temporal trends in the incidence, risk profiles, sex‐related differences, and outcomes in a contemporary population of young patients presenting with coronary artery disease ( CAD ) in British Columbia, Canada. Methods and Results: We used a provincial cardiac registry to identify young patients (men aged <50 years, women aged <55 years), with a first presentation of CAD between 2000 and 2016, who had either ≥50% stenosis of ≥1 coronary arteries on angiography or underwent coronary revascularization. A total of 12 519 patients (30% women) met our inclusion criteria. The incidence of CAD remained stable and was higher for men than women (46–53 versus 18–23 per 100 000). Of patients, 92% had at least one traditional cardiovascular risk factor and 67% had multiple risk factors. The prevalence of diabetes mellitus, obesity, and hypertension increased during the study period and was higher for women. Women had fewer emergent procedures and revascularizations. Mortality rates decreased by 31% between 2000 and 2007, then were stable for the remaining 9 years. Mortality was significantly higher for women aged <45 years compared with men. Conclusions: The incidence of premature CAD has not declined, and the prevalence of 3 major cardiovascular risk factors increased between 2000 and 2016. The risk burden and mortality rates were worse for women. These data have important implications for the design of strategies to prevent CAD in young adults.
- 16 July 2019
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (14) , e012178
Open AccessPremature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex‐Related Differences, 2000 to 2016
Background: The incidence of atherosclerotic cardiovascular disease has declined in the past 2 decades. However, these benefits may not extend to young patients. The objective of this work was to assess temporal trends in the incidence, risk profiles, sex‐related differences, and outcomes in a contemporary population of young patients presenting with coronary artery disease ( CAD ) in British Columbia, Canada. Methods and Results: We used a provincial cardiac registry to identify young patients (men aged <50 years, women aged <55 years), with a first presentation of CAD between 2000 and 2016, who had either ≥50% stenosis of ≥1 coronary arteries on angiography or underwent coronary revascularization. A total of 12 519 patients (30% women) met our inclusion criteria. The incidence of CAD remained stable and was higher for men than women (46–53 versus 18–23 per 100 000). Of patients, 92% had at least one traditional cardiovascular risk factor and 67% had multiple risk factors. The prevalence of diabetes mellitus, obesity, and hypertension increased during the study period and was higher for women. Women had fewer emergent procedures and revascularizations. Mortality rates decreased by 31% between 2000 and 2007, then were stable for the remaining 9 years. Mortality was significantly higher for women aged <45 years compared with men. Conclusions: The incidence of premature CAD has not declined, and the prevalence of 3 major cardiovascular risk factors increased between 2000 and 2016. The risk burden and mortality rates were worse for women. These data have important implications for the design of strategies to prevent CAD in young adults.
- 1 March 2014
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 52 (1) , 49-55
EFFICACY OF PHYSICAL EXERCISES IN PATIENTS WITH OSTEOPOROTIC VERTEBRAL FRACTURES
Переломы позвонков при остеопорозе (ОП) сопровождаются снижением качества жизни (КЖ) и функциональными ограничениями. Физические упражнения часто рекомендуются таким пациентам с целью уменьшения боли, улучшения КЖ и функционального состояния. Цель – оценить влияние физических упражнений на КЖ, функциональные показатели, равновесие у пациентов с остеопоретическими переломами позвонков. Материал и методы. В исследование включено 78 женщин с переломами позвонков и хронической болью в спине (40 в основной и 38 в контрольной группе). Средний возраст в основной группе составил 70,7±8,1 года, в контрольной – 67,6±7,0 года (p=0,35). Изучаемые показатели перед началом исследования статистически значимо не различались между группами. Занятия физическими упражнениями в основной группе проводились по 40 мин 2 раза в неделю в течение 12 мес. Пациентам контрольной группы было рекомендовано придерживаться физической активности, которая была до начала исследования. Оценка изучаемых показателей в начале исследования и через 12 мес проводилась с помощью опросника QUALEFFO-41, компьютерной системы диагностики нарушения равновесия и теста «Встань и иди». Результаты. Через 12 мес в основной группе получено статистически значимое улучшение КЖ, как по общему баллу (41,2) по сравнению с контролем (57,3; рВыводы. Физические упражнения улучшают КЖ, функциональную активность и равновесие у пациентов с остеопоретическими переломами позвонков.
- 1 March 2014
- Published by Mediar Press in Rheumatology Science and Practice
- Vol. 52 (1) , 49-55
EFFICACY OF PHYSICAL EXERCISES IN PATIENTS WITH OSTEOPOROTIC VERTEBRAL FRACTURES
Переломы позвонков при остеопорозе (ОП) сопровождаются снижением качества жизни (КЖ) и функциональными ограничениями. Физические упражнения часто рекомендуются таким пациентам с целью уменьшения боли, улучшения КЖ и функционального состояния. Цель – оценить влияние физических упражнений на КЖ, функциональные показатели, равновесие у пациентов с остеопоретическими переломами позвонков. Материал и методы. В исследование включено 78 женщин с переломами позвонков и хронической болью в спине (40 в основной и 38 в контрольной группе). Средний возраст в основной группе составил 70,7±8,1 года, в контрольной – 67,6±7,0 года (p=0,35). Изучаемые показатели перед началом исследования статистически значимо не различались между группами. Занятия физическими упражнениями в основной группе проводились по 40 мин 2 раза в неделю в течение 12 мес. Пациентам контрольной группы было рекомендовано придерживаться физической активности, которая была до начала исследования. Оценка изучаемых показателей в начале исследования и через 12 мес проводилась с помощью опросника QUALEFFO-41, компьютерной системы диагностики нарушения равновесия и теста «Встань и иди». Результаты. Через 12 мес в основной группе получено статистически значимое улучшение КЖ, как по общему баллу (41,2) по сравнению с контролем (57,3; рВыводы. Физические упражнения улучшают КЖ, функциональную активность и равновесие у пациентов с остеопоретическими переломами позвонков.